Notice: This company has been marked as potentially delisted and may not be actively trading. Acasti Pharma (ACST) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Acasti Pharma Short Interest DataAcasti Pharma (ACST) has a short interest of 154,200 shares, representing 2.47% of the float (the number of shares available for trading by the public). This marks a 19.63% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.7, indicating that it would take 5.7 days of the average trading volume of 22,722 shares to cover all short positions.Current Short Interest154,200 sharesPrevious Short Interest128,900 sharesChange Vs. Previous Month+19.63%Dollar Volume Sold Short$522,738.00Short Interest Ratio5.7 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares9,399,000 sharesFloat Size6,250,000 sharesShort Percent of Float2.47%Today's Trading Volume27,800 sharesAverage Trading Volume22,722 sharesToday's Volume Vs. Average122% Short Selling Acasti Pharma? Sign up to receive the latest short interest report for Acasti Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartACST Short Interest Over TimeACST Days to Cover Over TimeACST Percentage of Float Shorted Over Time Ad Weiss RatingsNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. Acasti Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2024154,200 shares $522,738.00 +19.6%2.5%5.7 $3.39 9/30/2024128,900 shares $386,700.00 +3,205.1%2.1%6.2 $3.00 9/15/20243,900 shares $8,932.17 -22.0%0.1%0.2 $2.29 8/31/20245,000 shares $13,100.00 +900.0%0.1%0.4 $2.62 8/15/2024500 shares $1,250.00 -83.9%0.0%0 $2.50 7/31/20243,100 shares $8,370.00 -49.2%0.1%0.2 $2.70 Get the Latest News and Ratings for ACST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter. 7/15/20246,100 shares $18,727.00 +281.3%0.1%0.5 $3.07 6/30/20241,600 shares $4,672.00 -72.9%0.0%0.1 $2.92 6/15/20245,900 shares $19,031.04 +34.1%0.1%0.3 $3.23 5/31/20244,400 shares $12,056.00 +300.0%0.1%0.2 $2.74 5/15/20241,100 shares $2,970.00 No Change0.0%0.1 $2.70 4/30/20241,100 shares $3,058.00 -71.1%0.0%0 $2.78 4/15/20243,800 shares $12,768.00 +171.4%0.1%0.1 $3.36 3/31/20241,400 shares $4,795.00 -78.8%0.0%0 $3.43 3/15/20246,600 shares $22,506.00 -71.6%0.1%0.2 $3.41 2/29/202423,200 shares $77,488.00 +105.3%0.3%0.8 $3.34 2/15/202411,300 shares $34,578.00 -52.1%0.2%0.4 $3.06 1/31/202423,600 shares $59,472.00 +20.4%0.4%1.1 $2.52 1/15/202419,600 shares $52,528.00 -73.5%0.3%0.9 $2.68 12/31/202373,900 shares $213,571.00 +23.8%1.1%3.5 $2.89 12/15/202359,700 shares $128,355.00 -22.3%0.9%1.1 $2.15 11/30/202376,800 shares $166,656.00 -16.4%1.3%1.5 $2.17 11/15/202391,900 shares $200,342.00 -10.0%1.5%1.9 $2.18 10/31/2023102,100 shares $240,956.00 -8.8%2.1%2 $2.36 10/15/2023112,000 shares $291,200.00 -48.9%2.4%2.2 $2.60 9/30/2023219,200 shares $610,143.20 +1,401.4%4.6%3.9 $2.78 9/15/202314,600 shares $29,054.00 -22.8%0.3%0.3 $1.99 8/31/202318,900 shares $39,690.00 -19.6%0.4%0.7 $2.10 8/15/202323,500 shares $52,875.00 +27.7%0.4%0.9 $2.25 7/31/202318,400 shares $47,472.00 +10.2%0.3%0.7 $2.58 7/15/202316,700 shares $41,750.00 -46.1%0.2%0.7 $2.50 6/30/202331,000 shares $97,668.60 -89.7%N/A1.5 $3.15 6/15/2023301,400 shares $173,274.86 -28.0%0.8%4.8 $0.57 5/31/2023418,300 shares $225,882.00 -19.5%1.1%7 $0.54 5/15/2023519,500 shares $252,165.30 +1.5%1.3%8.6 $0.49 4/30/2023511,900 shares $232,402.60 -2.4%1.3%8.4 $0.45 4/15/2023524,300 shares $246,316.14 +3.6%1.3%6.9 $0.47 3/31/2023506,300 shares $232,847.37 +5.4%1.3%5.4 $0.46 3/15/2023480,600 shares $211,464.00 +58.1%1.4%2.4 $0.44 2/28/2023303,900 shares $155,596.80 +41.1%0.9%1.4 $0.51This Crypto Is Set to Explode in December (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 2/15/2023215,400 shares $137,877.54 +31.9%0.6%1 $0.64 1/31/2023163,300 shares $115,959.33 -18.6%0.5%0.7 $0.71 1/15/2023200,700 shares $142,497.00 -50.0%0.6%0.9 $0.71 12/30/2022401,100 shares $200,951.10 +537.7%1.2%2 $0.50 12/15/202262,900 shares $22,165.96 +103.6%0.2%0.5 $0.35 11/30/202230,900 shares $12,940.92 -42.2%0.1%0.4 $0.42 11/15/202253,500 shares $26,599.29 -41.7%0.2%0.8 $0.50 10/31/202291,700 shares $51,902.20 -13.9%0.3%1.5 $0.57 10/15/2022106,500 shares $58,575.00 -22.2%0.3%1.6 $0.55 9/30/2022136,900 shares $79,881.15 -4.3%0.4%2 $0.58 9/15/2022143,000 shares $112,398.00 -7.1%0.4%2 $0.79 8/31/2022154,000 shares $125,294.40 -32.2%0.4%2 $0.81 8/15/2022227,200 shares $215,840.00 -20.4%0.7%2.6 $0.95 7/31/2022285,400 shares $236,339.74 -13.7%0.9%2.7 $0.83 7/15/2022330,500 shares $285,882.50 -58.1%1.0%3.3 $0.87 6/30/2022788,700 shares $681,436.80 -9.5%2.5%7.4 $0.86 6/15/2022871,500 shares $834,897.00 -26.1%2.7%7.3 $0.96 5/31/20221,180,000 shares $1.16 million +3.5%3.7%8.9 $0.98 5/15/20221,140,000 shares $1.03 million -14.9%3.6%7.3 $0.90 4/30/20221,340,000 shares $1.41 million -5.0%4.2%8.3 $1.05 4/15/20221,410,000 shares $1.69 million -8.4%4.4%7.2 $1.20 3/31/20221,540,000 shares $1.88 million -19.4%4.8%5.8 $1.22 3/15/20221,910,000 shares $1.89 million -11.6%6.0%1.3 $0.99 2/28/20222,160,000 shares $2.42 million -5.3%6.8%1.5 $1.12 2/15/20222,280,000 shares $2.92 million -3.0%7.2%1.5 $1.28 1/31/20222,350,000 shares $2.70 million +1.7%7.4%1.5 $1.15 1/15/20222,310,000 shares $3.21 million +1.3%7.3%1.5 $1.39 12/31/20212,280,000 shares $2.87 million +157.8%7.2%1.5 $1.26 12/15/2021884,400 shares $946,308.00 -8.0%2.8%0.6 $1.07 11/30/2021961,700 shares $1.30 million +2.1%3.0%1.9 $1.35 11/15/2021941,900 shares $1.50 million -9.4%2.7%1.4 $1.59 10/29/20211,040,000 shares $1.74 million +2.0%3.0%1.4 $1.67 10/15/20211,020,000 shares $1.77 million No Change2.9%1.3 $1.74 9/30/20211,020,000 shares $2.04 million +53.0%2.9%1.1 $2.00 9/15/2021666,500 shares $1.47 million +63.2%1.9%0.7 $2.21 8/31/2021408,500 shares $1.09 million -86.7%1.0%0.3 $2.67 8/13/20213,060,000 shares $1.38 million +21.9%1.5%0.3 $0.45 7/30/20212,510,000 shares $1.15 million -9.7%1.2%0.2 $0.46 7/15/20212,780,000 shares $1.47 million -11.8%1.4%0.2 $0.53 6/30/20213,150,000 shares $1.77 million -0.6%1.5%0.2 $0.56 6/15/20213,170,000 shares $1.66 million -31.2%1.5%0.2 $0.53 5/28/20214,610,000 shares $2.30 million +5.7%2.2%0.4 $0.50 5/14/20214,360,000 shares $1.89 million +10.4%2.1%0.3 $0.43 4/30/20213,950,000 shares $1.96 million +32.6%1.9%0.2 $0.50 4/15/20212,980,000 shares $1.39 million -0.7%1.5%0.1 $0.47 3/31/20213,000,000 shares $1.77 million -16.2%1.5%0.1 $0.59 3/15/20213,580,000 shares $2.59 million +169.2%1.8%0.1 $0.72 2/26/20211,330,000 shares $1.02 million -25.3%0.7%0 $0.77 2/12/20211,780,000 shares $1.98 million -20.5%1.0%0 $1.11 1/29/20212,240,000 shares $1.56 million +40.9%1.3%0.1 $0.69This Crypto Is Set to Explode in December (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 1/15/20211,590,000 shares $1.01 million +428.2%1.7%0 $0.63 12/31/2020301,000 shares $107,607.50 -40.6%0.3%0 $0.36 12/15/2020506,800 shares $126,750.68 -40.7%0.5%0 $0.25 11/30/2020854,400 shares $215,906.88 +57.2%0.9%0.1 $0.25 11/15/2020543,500 shares $113,156.70 +18.9%0.6%0.1 $0.21 10/30/2020457,100 shares $86,666.16 -75.2%0.5%0.1 $0.19 10/15/20201,840,000 shares $397,992.00 +34.3%2.0%0.3 $0.22 9/30/20201,370,000 shares $274,274.00 +25.7%1.5%0.2 $0.20 9/15/20201,090,000 shares $218,000.00 +141.3%1.2%0.2 $0.20 8/31/2020451,800 shares $110,555.46 +87.9%0.5%0.1 $0.24 8/14/2020240,500 shares $170,755.00 +8.2%0.3%0.1 $0.71 7/31/2020222,200 shares $168,872.00 -65.6%0.3%0.1 $0.76 7/15/2020646,000 shares $445,740.00 +20.9%0.7%0.3 $0.69 6/30/2020534,200 shares $250,593.22 +40.0%0.6%0.2 $0.47 6/15/2020381,500 shares $301,385.00 +81.2%0.5%0.2 $0.79 5/29/2020210,500 shares $133,246.50 -29.5%0.3%0.1 $0.63 5/15/2020298,500 shares $186,592.35 -37.6%0.4%0.2 $0.63 4/30/2020478,400 shares $291,824.00 +48.5%0.6%0.3 $0.61 4/15/2020322,100 shares $151,387.00 -10.4%0.4%0.1 $0.47 3/31/2020359,300 shares $194,022.00 -39.9%0.5%0.1 $0.54 3/13/2020597,300 shares $232,947.00 -48.1%0.8%0.6 $0.39 2/28/20201,150,000 shares $356,500.00 -1.7%1.5%0.2 $0.31 2/14/20201,170,000 shares $468,000.00 -10.7%1.5%0.2 $0.40 1/31/20201,310,000 shares $615,700.00 -42.0%1.9%0.3 $0.47 1/15/20202,260,000 shares $1.24 million +16.5%3.3%0.5 $0.55 12/31/20191,940,000 shares $1.30 million +3.7%2.9%0.5 $0.67 ACST Short Interest - Frequently Asked Questions What is Acasti Pharma's current short interest? Short interest is the volume of Acasti Pharma shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 154,200 shares of ACST short. 2.47% of Acasti Pharma's shares are currently sold short. Learn More on Acasti Pharma's current short interest. What is a good short interest ratio for Acasti Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACST shares currently have a short interest ratio of 6.0. Learn More on Acasti Pharma's short interest ratio. What is a good short interest percentage for Acasti Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.47% of Acasti Pharma's floating shares are currently sold short. Is Acasti Pharma's short interest increasing or decreasing? Acasti Pharma saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 154,200 shares, an increase of 19.6% from the previous total of 128,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Acasti Pharma's float size? Acasti Pharma currently has issued a total of 9,399,000 shares. Some of Acasti Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acasti Pharma currently has a public float of 6,250,000 shares. How does Acasti Pharma's short interest compare to its competitors? 2.47% of Acasti Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Acasti Pharma: Inventiva S.A. (0.67%), Acumen Pharmaceuticals, Inc. (3.09%), Metagenomi, Inc. (1.45%), Protara Therapeutics, Inc. (14.64%), Leap Therapeutics, Inc. (4.97%), X4 Pharmaceuticals, Inc. (7.33%), INmune Bio, Inc. (16.73%), Adverum Biotechnologies, Inc. (11.10%), Cardiol Therapeutics Inc. (1.46%), Journey Medical Co. (0.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Acasti Pharma stock? Short selling ACST is an investing strategy that aims to generate trading profit from Acasti Pharma as its price is falling. ACST shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Acasti Pharma? A short squeeze for Acasti Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACST, which in turn drives the price of the stock up even further. How often is Acasti Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACST, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies IVA Short Interest Data ABOS Short Interest Data MGX Short Interest Data TARA Short Interest Data LPTX Short Interest Data XFOR Short Interest Data INMB Short Interest Data ADVM Short Interest Data CRDL Short Interest Data DERM Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACST) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acasti Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acasti Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
